Published on 20/11/2025

Sponsor–CRO Collaboration on Feasibility to Minimize Non-Compliance

In the realm of registrational clinical trials, ensuring compliance with the protocol is critical to both participant safety and the integrity of the collected data. Non-compliance can not only result in wasted resources but can also jeopardize the overall success of a clinical program. This step-by-step tutorial serves to outline collaborative strategies for Sponsors and Contract Research Organizations (CROs) focused on minimizing non-compliance through effective feasibility assessments.

Understanding the Concept of Feasibility in Clinical Trials

Feasibility assessments involve the evaluation of various elements before the initiation of a clinical trial. This process helps determine whether a proposed study can be conducted effectively within the required parameters. Under GCP (Good Clinical Practice) guidelines, it is crucial to evaluate site readiness, patient recruitment capabilities, regulatory compliances, and more.

The feasibility phase is not merely an administrative formality; it serves as a foundation for the trial design and operational planning. Significant factors influencing feasibility assessments include:

• Site Selection: Identifying and evaluating sites that have a proven track record in conducting clinical trials.
• Patient Demographics: Understanding the patient population and their eligibility criteria to ensure adequate recruitment.
• Regulatory Landscape: Familiarity with local regulations that might impact the trial’s execution.
• Timeline Assessment: Estimating the duration for recruitment and the trial as a whole.

By collaboratively analyzing these factors, Sponsors and CROs can significantly improve the chances of trial success and participant retention, thereby minimizing the risk of protocol deviations.

Key Steps in Conducting a Collaborative Feasibility Assessment

To enhance the feasibility assessment process, Sponsors should follow a systematic approach that ensures thorough evaluation and collaboration with the CRO. The following step-by-step guide is designed to explain this process in detail.

Step 1: Define the Scope of the Study

The initial step in conducting a feasibility assessment involves precisely defining the scope and objectives of the clinical trial. This entails:

• Clarifying the primary and secondary objectives of the study.
• Identifying the therapeutic area and expected outcomes.
• Specifying eligibility criteria that will guide participant selection.

Clear objectives will guide subsequent assessments and inform the Sponsor and CRO about the necessary resources and capabilities of potential trial sites.

Step 2: Engage in Site Assessments

Once the study scope is defined, engaging in site assessments is crucial. Consider the following actions:

• Evaluate potential sites based on historical performance in similar ibm clinical trials and nci clinical trials.
• Assess sites’ infrastructure, including availability of necessary medical equipment and trained staff.
• Conduct on-site visits to better understand the capabilities and readiness of the sites.

This step not only helps in identifying suitable trial sites but also fosters communication between Sponsors and CROs, setting a collaborative tone for the project.

Step 3: Utilize Data Analytics for Recruitment Forecasting

Data analytics play a pivotal role in forecasting patient recruitment. By analyzing historical data and leveraging existing databases, both Sponsors and CROs can predict potential participant enrolment rates. Focus on:

• Utilizing tools that analyze past clinical trials to derive insights on recruitment challenges.
• Identifying patient demographics that align with the study’s inclusion criteria.
• Evaluating patterns in patient engagement and dropping out rates from previous trials.

Using predictive analysis not only reduces uncertainty but also enables proactive planning which is essential to navigate any compliance risks down the line.

Step 4: Communicate Clearly and Collaborate

A collaborative effort requires clear communication between the Sponsor and the CRO. Employ the following communication strategies:

• Establish regular meetings to discuss feasibility findings.
• Utilize project management tools that allow real-time updates on various aspects of the study.
• Encourage feedback where team members can voice concerns regarding feasibility.

The goal here is to create an environment where all stakeholders feel empowered to contribute, which leads to better compliance strategies during the clinical trial.

Challenges in Feasibility Assessments and Overcoming Them

While feasibility assessments are invaluable, various challenges can hinder their success. Addressing these issues promptly can lead to better outcomes. The following outlines common challenges and practical solutions.

Challenge 1: Incomplete Data

One of the most frequent challenges faced during feasibility assessments is incomplete or inaccurate data about sites and patient demographics. To mitigate this risk, consider the following:

• Use a centralized database that collects extensive site-level data.
• Regularly audit and update the database to ensure accuracy.
• Leverage relationships with local investigators to obtain supplementary data.

Challenge 2: Overestimating Patient Recruitment

Sometimes assessments lead to unrealistic expectations about patient recruitment due to lack of understanding of the local population. To overcome this:

• Conduct smaller pilot studies or surveys prior to the main study to gauge recruitment feasibility.
• Engage patient advocacy groups to better understand the patient landscape.
• Assess participant motivations and barriers to joining clinical trials.

Challenge 3: Regulatory Hurdles

Navigating the regulatory landscape in different regions, such as the US, UK, and EU, can be complex. To simplify compliance with local regulations:

• Stay updated with the latest guidelines provided by regulatory agencies.
• Incorporate regulatory representatives during the feasibility assessment stage to identify requirements early.
• Utilize resources like FDA and EMA for comprehensive regulatory understanding.

Implementing Learnings to Enhance Future Feasibility Assessments

After completing a clinical trial, it is critical to retrospectively analyze the feasibility assessment and its impact on trial execution. Applying lessons learned can significantly improve future collaborations between Sponsors and CROs. Consider the following steps:

Step 1: Conduct a Post-Assessment Review

A review of the feasibility assessment outcomes should be conducted after the trial’s completion. Focus on:

• The effectiveness of site selections and recruitment strategies.
• The adherence to the protocol and incidences of non-compliance.
• Factors influencing participant retention and trial success rates.

Step 2: Update Feasibility Guidelines Based on Data

Based on the review findings, update the feasibility guidelines to reflect real-world challenges faced during the trial. This includes:

• Incorporating new strategies tailored to the evolving regulatory landscape.
• Enhancing communication strategies based on past experiences.
• Adjusting expected timelines for patient recruitment based on actual performance data.

Step 3: Train Teams on Lessons Learned

Providing training to teams involved in future feasibility assessments can ensure continuous improvement. Key areas of focus include:

• Updating teams on new regulatory updates and compliance requirements.
• Facilitating workshops on effective data collection and analysis techniques.
• Sharing experiences and insights from previously conducted trials.

Conclusion

The synergy between Sponsors and CROs is essential for effectively navigating the complexities of registrational clinical trials. By methodically conducting feasibility assessments and applying calculated strategies, adherence to protocols can be significantly improved. The collaborative approach not only minimizes risks related to non-compliance but also paves the way for successful and timely clinical trial outcomes. Ultimately, an effective feasibility process will prepare teams to better engage with the intricacies of future clinical trials, leading to a more streamlined experience for all stakeholders involved.

As the industry continues to evolve, the importance of ongoing collaboration and rigorous feasibility evaluations will remain paramount to the success of clinical research endeavors. With proactive planning and a commitment to compliance, clinical trial professionals can ensure that they are best positioned to join clinical trials that advance scientific discovery.